Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Paper
  • Published:

A new role for the oncogenic high-mobility group A2 transcription factor in myogenesis of embryonic stem cells

Oncogene volume 24, pages 6281–6291 (2005)Cite this article

Abstract

The high mobility group type A-2 (HMGA2) transcription factor is involved in proliferation and differentiation, mainly during embryogenesis. Its activated form (HMGA2/T) presents oncogenic activities both in vivo and in vitro. However, its precise role during embryogenesis is unknown. We investigated its role during the commitment of mouse embryonic stem (ES) cells by constructing cell lines expressing either wild type (wt) or HMGA2/T forms of the gene. Following differentiation, control and wt HMGA2 ES cells did not display myotubes; whereas HMGA2/T ES cell lines massively formed contractile myotubes. Furthermore, as opposed to control cells, HMGA2/T ES cells highly expressed the muscle myosin heavy chain (MHC) marker. Interestingly, in experimental conditions inhibitory for myogenesis, we observed a strong expression of MyoD and myogenin in HMGA2/T cells. By contrast, commitment into adipocyte, neuron, and cardiomyocyte lineages was not affected. Teratocarcinomas induced by HMGA2/T ES cell lines presented numerous skeletal muscle-differentiated tissues that were not observed in wt HMGA2 or control tumours. Finally, rapamycin, an inhibitor of the mTOR kinase, downregulated endogenous HMGA-2 expression and inhibited myogenesis. This effect was prevented by overexpression of exogenous HMGA-2. Our results reveal a novel function of HMGA-2 in skeletal muscle differentiation.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
Figure 6
Figure 7

Similar content being viewed by others

References

  • Anand A and Chada K . (2000). Nat. Genet., 24, 377–380.

  • Anisimov SV, Tarasov KV, Riordon D, Wobus AM and Boheler KR . (2002). Mech. Dev., 117, 25–74.

  • Ashar HR, Fejzo MS, Tkachenko A, Zhou X, Fletcher JA, Weremowicz S, Morton CC and Chada K . (1995). Cell, 82, 57–65.

  • Baldassarre G, Fedele M, Battista S, Vecchione A, Klein-Szanto AJ, Santoro M, Waldmann TA, Azimi N, Croce CM and Fusco A . (2001). Proc. Natl. Acad. Sci. USA, 98, 7970–7975. Epub Jun 26, 2001.

  • Battista S, Fidanza V, Fedele M, Klein-Szanto AJ, Outwater E, Brunner H, Santoro M, Croce CM and Fusco A . (1999). Cancer Res., 59, 4793–4797.

  • Bost F, Caron L, Marchetti I, Dani C, Le Marchand-Brustel Y and Binetruy B . (2002). Biochem. J., 361, 621–627.

  • Chieffi P, Battista S, Barchi M, Di Agostino S, Pierantoni GM, Fedele M, Chiariotti L, Tramontano D and Fusco A . (2002). Oncogene, 21, 3644–3650.

  • Colmenares C and Stavnezer E . (1989). Cell, 59, 293–303.

  • Fedele M, Berlingieri MT, Scala S, Chiariotti L, Viglietto G, Rippel V, Bullerdiek J, Santoro M and Fusco A . (1998). Oncogene, 17, 413–418.

  • Gao X, Zhang Y, Arrazola P, Hino O, Kobayashi T, Yeung RS, Ru B and Pan D . (2002). Nat. Cell. Biol., 4, 699–704.

  • Hirning-Folz U, Wilda M, Rippe V, Bullerdiek J and Hameister H . (1998). Genes Chromosomes Cancer, 23, 350–357.

  • Hunter DS, Klotzbucher M, Kugoh H, Cai SL, Mullen JP, Manfioletti G, Fuhrman U and Walker CL . (2002). Cancer Res., 62, 3766–3772.

  • Molkentin JD and Olson EN . (1996). Curr. Opin. Genet. Dev., 6, 445–453.

  • Niwa H, Yamamura K and Miyazaki J . (1991). Gene, 108, 193–199.

  • Noro B, Licheri B, Sgarra R, Rustighi A, Tessari MA, Chau KY, Ono SJ, Giancotti V and Manfioletti G . (2003). Biochemistry, 42, 4569–4577.

  • Pende M, Um SH, Mieulet V, Sticker M, Goss VL, Mestan J, Mueller M, Fumagalli S, Kozma SC and Thomas G . (2004). Mol. Cell. Biol., 24, 3112–3124.

  • Reeves R and Beckerbauer L . (2001). Biochim. Biophys. Acta, 1519, 13–29.

  • Reeves R and Nissen M . (1999). Methods Enzymol., 304, 155–188.

  • Tallini G, Vanni R, Manfioletti G, Kazmierczak B, Faa G, Pauwels P, Bullerdiek J, Giancotti V, Van Den Berghe H and Dal Cin P . (2000). Lab. Invest., 80, 359–369.

  • Vernochet C, Milstone DS, Iehle C, Belmonte N, Phillips B, Wdziekonski B, Villageois P, Amri EZ, O'Donnell PE, Mortensen RM, Ailhaud G and Dani C . (2002). FEBS Lett., 510, 94–98.

  • Wobus AM . (2001). Mol. Aspects Med., 22, 149–164.

  • Zhou X, Benson KF, Ashar HR and Chada K . (1995). Nature, 376, 771–774.

  • Zhou X, Benson KF, Przybysz K, Liu J, Hou Y, Cherath L and Chada K . (1996). Nucleic Acids Res., 24, 4071–4077.

Download references

Acknowledgements

We thank Y Le Marchand-Brustel, J Vukmirica and JF Tanti for critical reading of the manuscript and Dr Niwa for the gift of CAG plasmid. This work was supported by Fondation Bettencourt-Schueller, ARC (Grants no. 4525 and 7720) and AFM (Grant no. 9986). LC was supported by fellowships from INSERM/Région Provence Alpes Côte d'Azur and the Ligue Nationale Contre le Cancer.

Author information

Authors and Affiliations

  1. INSERM U568, Signalisation Moléculaire et Obésité, Université de Nice Sophia-Antipolis, Faculté de Médecine, Avenue de Valombrose, Nice, 06107, cedex, France

    Leslie Caron, Frédéric Bost, Matthieu Prot & Bernard Binétruy

  2. INSERM E0215, Université de Nice Sophia-Antipolis, Faculté de Médecine, Avenue de Valombrose, Nice, 06107, cedex, France

    Paul Hofman

Authors
  1. Leslie Caron
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Frédéric Bost
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Matthieu Prot
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Paul Hofman
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Bernard Binétruy
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Bernard Binétruy.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Caron, L., Bost, F., Prot, M. et al. A new role for the oncogenic high-mobility group A2 transcription factor in myogenesis of embryonic stem cells. Oncogene 24, 6281–6291 (2005). https://doi.org/10.1038/sj.onc.1208781

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1208781

Keywords

This article is cited by

Search

Advanced search

Quick links